Evaluating muscle movement patterns and quality of life in patients with Duchenne Muscular Dystrophy.

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to assess trunk muscle compensatory movement patterns in patients with Duchenne Muscular Dystrophy (DMD) using advanced computer vision technology. It will investigate the correlation between these movement patterns and factors such as scoliosis, upper limb function, pain levels, and overall quality of life during functional movements. Participants will include individuals diagnosed with DMD and a healthy control group, with assessments including Cobb angle measurements and upper limb function evaluations. The study seeks to understand how these patterns and their relationships evolve over time.

Why it matters

Who can join: the full rules

1. Inclusion Criteria (1) Duchenne Muscular Dystrophy (DMD) Group

   * Individuals with a confirmed genetic diagnosis of Duchenne Muscular Dystrophy.
   * Aged over 10 years but under 30 years.
   * Brooke Scale score between 2 and 5.
   * Shoulder abductor muscle strength below grade 3 on the Manual Muscle Test (MMT).

     (2) Healthy Control Group
   * Individuals with no history or current diagnosis of musculoskeletal or neuromuscular disorders.
   * Aged over 10 years but under 30 years.
   * Shoulder muscle strength of grade 4+ or higher on the Manual Muscle Test (MMT).
   * Individuals capable of understanding a detailed explanation of the study procedures and voluntarily providing written informed consent.
2. Exclusion Criteria (1) Duchenne Muscular Dystrophy (DMD) Group

   * Individuals unable or unwilling to provide informed consent.
   * Brooke Scale score of 1 or 6.
   * Severe cognitive impairment preventing the performance of simple tasks. (2) Healthy Control Group
   * Individuals unable or unwilling to provide informed consent.
   * Shoulder muscle strength of grade 4 or lower on the Manual Muscle Test (MMT).

Where it's running

• Seoul National University Hospital
  Seoul, South Korea Recruiting

Study contacts

• Study coordinator: Sungbae Jo Research professor, Ph. D
• Email: rew277@gmail.com
• Phone: 82-10-9381-2299

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• How chronic pain changes over time in kids with Duchenne Muscular Dystrophy

  This study is following children and teens with Duchenne Muscular Dystrophy for 6 months to see how their chronic pain changes and how it affects daily life.

  Recruiting Antalya Training and Research Hospital · Antalya, Antalya · NCT07892196

• Bone health in adults with Duchenne muscular dystrophy: osteoporosis, fractures, and treatment

  This study looks at how common bone problems and fractures are in adults with Duchenne muscular dystrophy and what factors from childhood might affect bone health later on.

  Recruiting at 15 sites Istituto Giannina Gaslini · Bologna and 14 other locations · NCT07890883

• Respiratory progression in adults with Duchenne muscular dystrophy: a long-term observational study

  This study tests how respiratory function changes over three years in adults with genetically confirmed Duchenne muscular dystrophy.

  Recruiting at 13 sites Istituto Giannina Gaslini · Bologna and 12 other locations · NCT07879989

• Modeling heart failure in Duchenne and Becker muscular dystrophy to find surrogate heart measures

  This study will look at heart disease in people with Duchenne/Becker muscular dystrophy and carriers to see if MRI-based heart measures can predict death or major heart problems.

  Recruiting at 9 sites Vanderbilt University Medical Center · Sacramento, California and 8 other locations · NCT07674758

• Duchenne/Becker Muscular Dystrophy EHR Data Linkage

  This study tests whether consented patients’ electronic health records can be linked with the Duchenne Registry data to create a richer view of Duchenne and Becker muscular dystrophy care.

  Recruiting at 11 sites The Duchenne Registry · Little Rock, Arkansas and 10 other locations · NCT07609394

• Zeleciment Rostudirsen (DYNE-251) for Duchenne Muscular Dystrophy in Ambulatory Boys

  This trial tests whether intravenous Zeleciment Rostudirsen (DYNE-251) given every 4 weeks is safe and helps improve function in ambulatory boys with Duchenne muscular dystrophy who have a specific dystrophin gene mutation.

  Recruiting Phase 3 Dyne Therapeutics · Hillsborough, North Carolina · NCT07608432

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.